Yüklüyor......
Knockdown of NF-κB1 by shRNA Inhibits the Growth of Renal Cell Carcinoma In Vitro and In Vivo
Renal cell carcinoma (RCC) accounts for approximately 2%–3% of human malignancies and is the most aggressive among urologic tumors. Biological heterogeneity, drug resistance, and chemotherapy side effects are the biggest obstacles to the effective treatment of RCC. The NF-κB transcription factor is...
Kaydedildi:
| Yayımlandı: | Oncol Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cognizant Communication Corporation
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7844753/ https://ncbi.nlm.nih.gov/pubmed/29212573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504017X15120379906339 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|